Cargando…
Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10271592/ https://www.ncbi.nlm.nih.gov/pubmed/37332852 http://dx.doi.org/10.1002/pul2.12253 |
_version_ | 1785059394346549248 |
---|---|
author | Ahmed, Abdulla Ahmed, Salaheldin Rådegran, Göran |
author_facet | Ahmed, Abdulla Ahmed, Salaheldin Rådegran, Göran |
author_sort | Ahmed, Abdulla |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10271592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102715922023-06-17 Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines Ahmed, Abdulla Ahmed, Salaheldin Rådegran, Göran Pulm Circ Letter to the Editor John Wiley and Sons Inc. 2023-06-15 /pmc/articles/PMC10271592/ /pubmed/37332852 http://dx.doi.org/10.1002/pul2.12253 Text en © 2023 The Authors. Pulmonary Circulation published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Letter to the Editor Ahmed, Abdulla Ahmed, Salaheldin Rådegran, Göran Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines |
title | Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines |
title_full | Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines |
title_fullStr | Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines |
title_full_unstemmed | Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines |
title_short | Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines |
title_sort | risk assessment in pulmonary arterial hypertension: a step towards clinical implementation based on the 2022 esc/ers pulmonary hypertension guidelines |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10271592/ https://www.ncbi.nlm.nih.gov/pubmed/37332852 http://dx.doi.org/10.1002/pul2.12253 |
work_keys_str_mv | AT ahmedabdulla riskassessmentinpulmonaryarterialhypertensionasteptowardsclinicalimplementationbasedonthe2022escerspulmonaryhypertensionguidelines AT ahmedsalaheldin riskassessmentinpulmonaryarterialhypertensionasteptowardsclinicalimplementationbasedonthe2022escerspulmonaryhypertensionguidelines AT radegrangoran riskassessmentinpulmonaryarterialhypertensionasteptowardsclinicalimplementationbasedonthe2022escerspulmonaryhypertensionguidelines |